XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Supplemental data | 6 Months Ended
--- | ---
Jun. 30, 2016
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Supplemental data |
2 2. | Supplemental data
The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes. Condensed Consolidating Statements of Income
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the six months ended June 30, 2016 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Patient service operating revenues |  | $ | 5,048,392 |  |  | $ | 175,933 |  |  | $ | — |  |  | $ | 4,872,459 |
Less: Provision for uncollectible accounts |  |  | (220,633 | ) |  |  | (5,830 | ) |  |  | — |  |  |  | (214,803 | )
Net patient service operating revenues |  |  | 4,827,759 |  |  |  | 170,103 |  |  |  | — |  |  |  | 4,657,656 |
Capitated revenues |  |  | 1,784,873 |  |  |  | 802,431 |  |  |  | — |  |  |  | 982,442 |
Other revenues |  |  | 686,155 |  |  |  | 29,970 |  |  |  | — |  |  |  | 656,185 |
Total net operating revenues |  |  | 7,298,787 |  |  |  | 1,002,504 |  |  |  | — |  |  |  | 6,296,283 |
Operating expenses |  |  | 6,604,828 |  |  |  | 998,744 |  |  |  | (28 | ) |  |  | 5,606,112 |
Operating income |  |  | 693,959 |  |  |  | 3,760 |  |  |  | 28 |  |  |  | 690,171 |
Debt expense, including refinancing charges |  |  | (205,778 | ) |  |  | (8,405 | ) |  |  | — |  |  |  | (197,373 | )
Other income |  |  | 6,191 |  |  |  | 258 |  |  |  | — |  |  |  | 5,933 |
Income tax expense |  |  | 261,710 |  |  |  | 9,504 |  |  |  | 11 |  |  |  | 252,195 |
Net income (loss) |  |  | 232,662 |  |  |  | (13,891 | ) |  |  | 17 |  |  |  | 246,536 |
Less: Net income attributable to noncontrolling interests |  |  | (81,846 | ) |  |  | — |  |  |  | — |  |  |  | (81,846 | )
Net income (loss) attributable to DaVita HealthCare Partners Inc. |  | $ | 150,816 |  |  | $ | (13,891 | ) |  | $ | 17 |  |  | $ | 164,690 |
(1) | After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Statements of Comprehensive Income
|  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the six months ended June 30, 2016 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Net income (loss) |  | $ | 232,662 |  |  | $ | (13,891 | ) |  | $ | 17 |  |  | $ | 246,536 |
Other comprehensive loss |  |  | (61 | ) |  |  | — |  |  |  | — |  |  |  | (61 | )
Total comprehensive income (loss) |  |  | 232,601 |  |  |  | (13,891 | ) |  |  | 17 |  |  |  | 246,475 |
Less: comprehensive income attributable to the noncontrolling interests |  |  | (81,995 | ) |  |  | — |  |  |  | — |  |  |  | (81,995 | )
Comprehensive income (loss) attributable to DaVita HealthCare Partners Inc. |  | $ | 150,606 |  |  | $ | (13,891 | ) |  | $ | 17 |  |  | $ | 164,480 |
(1) | After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Balance Sheets
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
As of June 30, 2016 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Cash and cash equivalents |  | $ | 1,283,416 |  |  | $ | 81,620 |  |  | $ | — |  |  | $ | 1,201,796 |
Accounts receivable, net |  |  | 1,875,403 |  |  |  | 205,112 |  |  |  | — |  |  |  | 1,670,291 |
Other current assets |  |  | 1,337,398 |  |  |  | 18,155 |  |  |  | — |  |  |  | 1,319,243 |
Total current assets |  |  | 4,496,217 |  |  |  | 304,887 |  |  |  | — |  |  |  | 4,191,330 |
Property and equipment, net |  |  | 2,972,407 |  |  |  | 1,502 |  |  |  | — |  |  |  | 2,970,905 |
Amortizable intangibles, net |  |  | 1,631,001 |  |  |  | 5,393 |  |  |  | — |  |  |  | 1,625,608 |
Other long-term assets |  |  | 231,048 |  |  |  | 74,090 |  |  |  | 2,796 |  |  |  | 154,162 |
Goodwill |  |  | 9,360,957 |  |  |  | 16,234 |  |  |  | — |  |  |  | 9,344,723 |
Total assets |  | $ | 18,691,630 |  |  | $ | 402,106 |  |  | $ | 2,796 |  |  | $ | 18,286,728 |
Current liabilities |  | $ | 2,645,662 |  |  | $ | 225,660 |  |  | $ | — |  |  | $ | 2,420,002 |
Payables to parent |  |  | — |  |  |  | 70,352 |  |  |  | 2,796 |  |  |  | (73,148 | )
Long-term debt and other long-term liabilities |  |  | 10,150,362 |  |  |  | 51,585 |  |  |  | — |  |  |  | 10,098,777 |
Noncontrolling interests subject to put provisions |  |  | 936,903 |  |  |  | — |  |  |  | — |  |  |  | 936,903 |
Total DaVita HealthCare Partners Inc. shareholders’ equity |  |  | 4,746,054 |  |  |  | 54,509 |  |  |  | — |  |  |  | 4,691,545 |
Noncontrolling interests not subject to put provisions |  |  | 212,649 |  |  |  | — |  |  |  | — |  |  |  | 212,649 |
Shareholders’ equity |  |  | 4,958,703 |  |  |  | 54,509 |  |  |  | — |  |  |  | 4,904,194 |
Total liabilities and shareholder’s equity |  | $ | 18,691,630 |  |  | $ | 402,106 |  |  | $ | 2,796 |  |  | $ | 18,286,728 |
(1) | After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Statements of Cash Flows
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the six months ended June 30, 2016 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 232,662 |  |  | $ | (13,891 | ) |  | $ | 17 |  |  | $ | 246,536 |
Changes in operating and intercompany assets and liabilities and non-cash items included in net income |  |  | 712,977 |  |  |  | 144,876 |  |  |  | (17 | ) |  |  | 568,118 |
Net cash provided by operating activities |  |  | 945,639 |  |  |  | 130,985 |  |  |  | — |  |  |  | 814,654 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  |  | (358,627 | ) |  |  | (350 | ) |  |  | — |  |  |  | (358,277 | )
Acquisitions and divestitures, net |  |  | (473,314 | ) |  |  | — |  |  |  | — |  |  |  | (473,314 | )
Proceeds from discontinued operations |  |  | 17,393 |  |  |  | — |  |  |  | — |  |  |  | 17,393 |
Investments and other items |  |  | 56,319 |  |  |  | (1,465 | ) |  |  | — |  |  |  | 57,784 |
Net cash used in investing activities |  |  | (758,229 | ) |  |  | (1,815 | ) |  |  | — |  |  |  | (756,414 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt |  |  | (61,233 | ) |  |  | (4 | ) |  |  | — |  |  |  | (61,229 | )
Intercompany |  |  | — |  |  |  | (135,791 | ) |  |  | — |  |  |  | 135,791 |
Other items |  |  | (342,321 | ) |  |  | — |  |  |  | — |  |  |  | (342,321 | )
Net cash used in by financing activities |  |  | (403,554 | ) |  |  | (135,795 | ) |  |  | — |  |  |  | (267,759 | )
Effect of exchange rate changes on cash |  |  | 444 |  |  |  | — |  |  |  | — |  |  |  | 444 |
Net decrease in cash |  |  | (215,700 | ) |  |  | (6,625 | ) |  |  | — |  |  |  | (209,075 | )
Cash and cash equivalents at beginning of period |  |  | 1,499,116 |  |  |  | 88,245 |  |  |  | — |  |  |  | 1,410,871 |
Cash and cash equivalents at end of period |  | $ | 1,283,416 |  |  | $ | 81,620 |  |  | $ | — |  |  | $ | 1,201,796 |
(1) | After elimination of the unrestricted subsidiaries and the physician groups.

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration